CAREDX, INC. Revenues
CAREDX, INC. (CDNA) reported Revenues of $14.05 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-10.
Discontinued › Income Statement
us-gaap:Revenues · last filed 2018-05-10
- CAREDX, INC. revenues for the quarter ending 2018-03-31 was $14.05M, a 21.31% increase year-over-year.
- CAREDX, INC. revenues for the quarter ending 2017-12-31 was $12.50M, a 15.14% increase year-over-year.
- CAREDX, INC. revenues for the quarter ending 2017-09-30 was $12.19M, a 2.28% decline year-over-year.
- CAREDX, INC. revenues for the quarter ending 2017-06-30 was $12.05M, a 12.21% increase year-over-year.
- CAREDX, INC. revenues for fiscal 2017 was $48.32M, a 18.93% increase from fiscal 2016.
- CAREDX, INC. revenues for fiscal 2016 was $40.63M, a 44.37% increase from fiscal 2015.
- CAREDX, INC. revenues for fiscal 2015 was $28.14M, a 3.07% increase from fiscal 2014.
- CAREDX, INC. revenues for fiscal 2014 was $27.31M, a 23.57% increase from fiscal 2013.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2018-03-31 | $14.05M 10-Q · filed 2018-05-10 | $26.56M derived: sum of 2 quarters · filed 2018-05-10 | $38.75M derived: sum of 3 quarters · filed 2018-05-10 | $50.79M derived: sum of 4 quarters · filed 2018-05-10 |
| 2017-12-31 | $12.50M 10-K · filed 2018-03-22 | $24.69M derived: sum of 2 quarters · filed 2018-03-22 | $36.74M derived: sum of 3 quarters · filed 2018-03-22 | $48.32M 10-K · filed 2018-03-22 |
| 2017-09-30 | $12.19M 10-Q · filed 2017-11-09 | $24.24M derived: sum of 2 quarters · filed 2018-03-22 | $35.82M 10-Q · filed 2017-11-09 | $46.68M derived: sum of 4 quarters · filed 2018-05-10 |
| 2017-06-30 | $12.05M 10-K · filed 2018-03-22 | $23.63M 10-Q · filed 2017-08-11 | $34.49M derived: sum of 3 quarters · filed 2018-05-10 | $46.96M derived: sum of 4 quarters · filed 2018-05-10 |
| 2017-03-31 | $11.58M 10-Q · filed 2018-05-10 | $22.44M derived: sum of 2 quarters · filed 2018-05-10 | $34.92M derived: sum of 3 quarters · filed 2018-05-10 | $45.65M derived: sum of 4 quarters · filed 2018-05-10 |
| 2016-12-31 | $10.86M 10-K · filed 2018-03-22 | $23.33M derived: sum of 2 quarters · filed 2018-03-22 | $34.07M derived: sum of 3 quarters · filed 2018-03-22 | $40.63M 10-K · filed 2018-03-22 |
| 2016-09-30 | $12.47M 10-K · filed 2018-03-22 | $23.21M derived: sum of 2 quarters · filed 2018-03-22 | $29.77M 10-Q · filed 2017-11-09 | $36.42M derived: sum of 4 quarters · filed 2018-03-22 |
| 2016-06-30 | $10.73M 10-K · filed 2018-03-22 | $17.30M 10-Q · filed 2017-08-11 | $23.95M derived: sum of 3 quarters · filed 2018-03-22 | $31.10M derived: sum of 4 quarters · filed 2018-03-22 |
| 2016-03-31 | $6.56M 10-K · filed 2018-03-22 | $13.21M derived: sum of 2 quarters · filed 2018-03-22 | $20.36M derived: sum of 3 quarters · filed 2018-03-22 | $27.49M derived: sum of 4 quarters · filed 2018-03-22 |
| 2015-12-31 | $6.65M 10-K · filed 2017-04-21 | $13.80M derived: sum of 2 quarters · filed 2017-04-21 | $20.93M derived: sum of 3 quarters · filed 2017-04-21 | $28.14M 10-K · filed 2018-03-22 |
| 2015-09-30 | $7.15M 10-K · filed 2017-04-21 | $14.28M derived: sum of 2 quarters · filed 2017-04-21 | $21.50M 10-Q · filed 2016-11-14 | $29.45M derived: sum of 4 quarters · filed 2017-04-21 |
| 2015-06-30 | $7.13M 10-K · filed 2017-04-21 | $14.34M 10-Q · filed 2016-08-22 | $22.30M derived: sum of 3 quarters · filed 2017-04-21 | $28.95M derived: sum of 4 quarters · filed 2017-04-21 |
| 2015-03-31 | $7.22M 10-K · filed 2017-04-21 | $15.17M derived: sum of 2 quarters · filed 2017-04-21 | $21.82M derived: sum of 3 quarters · filed 2017-04-21 | $28.60M derived: sum of 4 quarters · filed 2017-04-21 |
| 2014-12-31 | $7.95M 10-K · filed 2016-03-29 | $14.61M derived: sum of 2 quarters · filed 2016-03-29 | $21.38M derived: sum of 3 quarters · filed 2016-03-29 | $27.31M 10-K · filed 2017-04-21 |
| 2014-09-30 | $6.65M 10-K · filed 2016-03-29 | $13.43M derived: sum of 2 quarters · filed 2016-03-29 | $19.35M 10-Q · filed 2015-11-13 | $25.21M derived: sum of 4 quarters · filed 2016-03-29 |
| 2014-06-30 | $6.78M 10-K · filed 2016-03-29 | $12.70M 10-Q · filed 2015-08-12 | $18.55M derived: sum of 3 quarters · filed 2016-03-29 | $24.36M derived: sum of 4 quarters · filed 2016-03-29 |
| 2014-03-31 | $5.92M 10-K · filed 2016-03-29 | $11.78M derived: sum of 2 quarters · filed 2016-03-29 | $17.58M derived: sum of 3 quarters · filed 2016-03-29 | $23.04M derived: sum of 4 quarters · filed 2016-03-29 |
| 2013-12-31 | $5.86M 10-K · filed 2015-03-31 | $11.66M derived: sum of 2 quarters · filed 2015-03-31 | $17.12M derived: sum of 3 quarters · filed 2015-03-31 | $22.10M 10-K · filed 2016-03-29 |
| 2013-09-30 | $5.80M 10-K · filed 2015-03-31 | $11.26M derived: sum of 2 quarters · filed 2015-03-31 | $16.24M 10-Q · filed 2014-11-14 | |
| 2013-06-30 | $5.46M 10-K · filed 2015-03-31 | $10.44M 10-Q · filed 2014-08-28 | ||
| 2013-03-31 | $4.98M 10-K · filed 2015-03-31 | |||
| 2012-12-31 | $20.45M 10-K · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |